 |
|
|
| |
INSPIRING: SAFETY AND EFFICACY OF DOLUTEGRAVIR-BASED ART IN TB/HIV COINFECTED ADULTS AT WEEK 24
|
| |
| |
Reported by Jules Levin
CROI 2018 Boston, MA March 4-7
WEBCAST: http://www.croiwebcasts.org/console/player/37073?mediaType=slideVideo&&crd_fl=1&ssmsrq=1522780732471&ctms=5000&csmsrq=893
Dooley KE,1 Kaplan R,2 Mwelase T,3 Grinsztejn B,4 Ticona E,5 Lacerda M,6 Cahn P,7 Belonosova E,8 Ait-Khaled M,9 Angelis K,10 Brown D,11 Singh R,12 Talarico C,13 Tenorio A,13 Aboud M9
1Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2Desmond Tutu HIV Foundation, Cape Town, South Africa; 3Clinical HIV Research Unit, Johannesburg, South Africa; 4Instituto de Pesquisa Clínica Evandro Chagas FIOCRUZ,
Rio de Janeiro, Brazil; 5Hospital Dos de Mayo, Lima, Peru; 6Fiocruz/Tropical Medicine Foundation Dr Heitor, Vieira Dourado, Manaus, Brazil; 7Fundación Huésped, Bueno Aires, Argentina; 8Regional Center for Prevention and Treatment of AIDS and Infectious Diseases, Russia; 9ViiV Healthcare, Brentford, UK; 10GlaxoSmithKline, Stockley Park, UK; 11ViiV Healthcare, Melbourne, Australia; 12ViiV Healthcare, Upper Merion, PA, USA; 13ViiV Healthcare, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
